Healthgen of Wuhan disputes USITC reliance on testing data, finding of domestic industry for Ventria Bioscience
Counsel for the US International Trade Commission at oral arguments today defended a limited exclusion order barring Healthgen of Wuhan from importing plant-derived recombinant human serum albumins and various rHSA-containing products...To view the full article, register now.
Already a subscriber? Click here to view full article